L
Lexicon Pharmaceuticals, Inc. (LXRX)
NCM – Real vaqt narxi. Valyuta: USD
2.41
+0.10 (4.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.43
+0.02 (0.82%)
Bozor oldidan: May 13, 2026, 7:08 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.41
+0.10 (4.33%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.43
+0.02 (0.82%)
Bozor oldidan: May 13, 2026, 7:08 AM EDT
Lexicon Pharmaceuticals, Inc., biotexnologiya kompaniyasi, inson kasalliklarini davolash uchun farmatsevtika mahsulotlarini kashf qilish, ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya gipertrofik kardiomiopatiyani davolash uchun og'iz orqali yuboriladigan kichik molekulali dori sotagliflozin va 1-toifa diabetni davolash uchun ZYNQUISTA (sotagliflozin)ni ishlab chiqadi. Shuningdek, u yurak etishmovchiligi, yurak etishmovchiligi tufayli kasalxonaga yotqizish va yurak etishmovchiligi yoki 2-toifa diabet, Buyrak surunkali kasalligi (CKD) va boshqa yurak-qon tomir xavf omillari bo'lgan kattalarda yurak etishmovchiligi bilan bog'liq shoshilinch tashriflar xavfini kamaytirish uchun kuniga bir marta qabul qilinadigan og'iz orqali qabul qilinadigan tabletka INPEFA (sotagliflozin)ni tijoratlashtiradi. Qo'shimcha ravishda, kompaniya semizlik va bog'liq kardiyometabolik kasalliklarni davolash uchun og'iz orqali yuboriladigan kichik molekulali dori nomzodi LX9851 va neyropatik og'riqni davolash uchun og'iz orqali yuboriladigan kichik molekulali dori nomzodi pilavapadin (LX9211)ni ishlab chiqadi. U Viatris Inc. va Bristol-Myers Squibb Company bilan strategik hamkorlik va litsenziyalash shartnomalariga ega. Kompaniya 1995 yilda tashkil etilgan va shtab-kvartirasi The Woodlands, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Craig B. Granowitz M.D., Ph.D. | Senior VP & Chief Medical Officer |
| Dr. Michael S. Exton Ph.D. | CEO & Director |
| Dr. Suma Gopinathan M.S., Ph.D. | Senior Vice President of Discovery |
| Mr. Brian T. Crum | Senior VP, General Counsel & Secretary |
| Mr. Scott M. Coiante | Senior VP & CFO |
| Ms. Kristen L. Alexander | Vice President of Finance & Accounting |
| Ms. Lisa M. DeFrancesco | Senior Vice President of Investor Relations & Corporate Communications |
| Ms. Rachel Yap Martens | Senior VP of Partnerships & Corporate Strategy |
| Ms. Wendy E. McDermott | Senior Vice President of Human Resources |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | lxrx-20260507.htm |
| 2026-05-07 | 10-Q | lxrx-20260331.htm |
| 2026-05-06 | 8-K | lxrx-20260504.htm |
| 2026-04-30 | 8-K | lxrx-20260430.htm |
| 2026-03-16 | DEFA14A | a2026proxynotice04-22x2026.htm |
| 2026-03-16 | ARS | a2025annualreport.htm |
| 2026-03-05 | 8-K | lxrx-20260305.htm |
| 2026-02-17 | PRE 14A | lxrx-20260217.htm |
| 2026-02-17 | D | |
| 2026-02-02 | 8-K | d32395d8k.htm |